Multihance at 3 Tesla (3T) in Brain Tumors

Completed · Phase 4

Conditions studied: Brain Tumor

In brief

Compare the efficacy of MultiHance and Magnevist

Key facts

Study ID

NCT00395863

Run by

Bracco Diagnostics, Inc

People needed

46

Starts

2006-11-01

Expected to finish

2008-03-01

Last updated by the study team

2020-11-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Was 18 years or older
• Provided written informed consent
• Scheduled for MRI
• Confirmed or highly suspected to have brain tumor(s) and willing to undergo two MRI exams within 14 days

You may not qualify if…

• Pregnant or lactating females
• Allergy to one or more of the ingredients in the products or hypersensitivity to any metals
• Congestive heart failure, class IV
• Previous stroke in the past year
• Received another contrast agent within 24 hours pre and post each exam
• Investigational product
• Contraindications to MRI
• Severe claustrophobia
• Surgery with 3 weeks prior
• Steroid therapy or radiosurgery between two exams

Where it is running

• Bracco Diagnostics, Inc. — Princeton, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.